{
    "nctId": "NCT00843167",
    "briefTitle": "Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy",
    "officialTitle": "Sulforaphane: A Dietary Histone Deacetylase (HDAC) Inhibitor in Ductal Carcinoma in Situ (DCIS)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Precancerous Condition",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 54,
    "primaryOutcomeMeasure": "Change in Isothiocyanate in Urine Samples as Assessed at Baseline and After Completion of Study Therapy",
    "eligibilityCriteria": "INCLUSION CRITERIA:\n\n* Diagnostic mammogram\n* English speaking\n\nEXCLUSION CRITERIA:\n\n* Pregnancy (as determined by urine human chorionic gonadotropin (hCG) test)\n* No biopsy referral after diagnostic mammogram\n* Patient reported breast feeding\n* Significant active medical illness which in the opinion of the investigator would preclude protocol treatment\n* History of or active liver disease or baseline total bilirubin greater than institutional upper limit of normal\n* Patient reported allergy or sensitivity to cruciferous vegetables\n* Use of oral antibiotics within three months prior to randomization\n* Oral steroid therapy at enrollment\n* Current therapy with valproate acid or SAHA\n* Current use of nutrient supplements or herbal remedies containing sulforaphane and unwillingness or inability to quit 72 hours prior to randomization and for the duration of the trial\n* Radiation for currently-diagnosed disease prior to or during study supplementation\n* Chemotherapy for currently-diagnosed disease prior to or during study supplementation",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}